ulinastatin Usage.

　　(1) acute pancreatitis, chronic recurrent pancreatitis, the initial l00,000 units each time dissolved in 500ml 5% glucose injection or 0.9% normal saline injection in the intravenous drip, each time static drip 1 to 2 hours, 1 to 3 times a day, after the symptoms subside; (2) acute circulatory failure, or 100,000 units each time in 2 ml 0.9% normal saline injection, daily slow intravenous injection 1 ~ 3 times. And can increase or decrease appropriately according to age, symptom.

　　Adverse reactions

　　Blood system: leukopenia or eosinophil can be seen occasionally; (2) the digestive system: nausea, vomiting, diarrhea occasionally, occasionally increased AST, ALT; (3) injection site: vascular pain, redness, pruritus, rash, etc. Occasionally see allergies, allergic symptoms should immediately stop the drug, and appropriate treatment.

　　Matters needing attention

　　Have a history of drug allergy, allergic to food or allergic to the constitution of patients with caution. When this product is used in acute circulatory failure, it should be noted that it cannot replace general shock therapy (infusion, oxygen inhalation, surgical treatment, antibiotics, etc.), and the drug administration shall be terminated after the symptoms of shock are improved. (3) please note that this product should be used quickly after dissolution.

　　Drug interaction

　　Avoid mixing with gabel or globulin.